Hyperbaric Oxygen Therapy Treatment of Chronic Mild Traumatic Brain Injury (mTBI)/Persistent Post-Concussion Syndrome (PPCS)


This is a randomized prospective controlled single-blind crossover clinical trial of 1.5 ATA
(atmospheres absolute) HBOT versus maintenance medication and counseling. One hundred adult
subjects (50 at Louisiana State University Health Sciences Center-New Orleans and 50 at
Oklahoma State University School of Medicine) with mTBI/PPCS who have been symptomatic
continuously for at least six months from one or more mild traumatic brain injuries will be
enrolled and randomized to either 40 HBOTs or no treatment. After the 8-week treatment period
the no treatment group will be crossed over to receive 40 HBOTs.


Post-Concussion Syndrome


Hyperbaric Oxygen

Start Date:

May 2014


Louisiana State University Health Sciences Center in New Orleans

For More Information: